Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Lexapro – Treatment of Major Depressive Disorder in Adolescents

Drug (Brand / Generic)

Lexapro (escitalopram oxalate)

Chemical Name

S-(+)-1-[3-(dimethylamino)propyl]-1-(4'-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile

Molecular Formula

C<span class="sub">20</span>H<span class="sub">21</span>FN<span class="sub">2</span>O, C<span class="sub">2</span>H<span class="sub">2</span>O<span class="sub">4</span> (as oxalate)

Molecular Weight

414.40 (as oxalate)

Launch Date

2002

Therapy Class

Selective serotonin reuptake inhibitors (SSRIs)

Therapeutic Segment

CNS

Development Status / Regulatory Approvals

Approved by FDA for adolescents (12-17 yrs)

Company / Licensee

Forest Laboratories Inc.

Partner

Lundbeck
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM

Go Top